Identifying Barriers to Allo Stem Cell Transplants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Observational Trial
- Enrollment
- 1,365 patients (estimated)
- Sponsors
- Memorial Sloan Kettering Cancer Center
- Tags
- Pre-Allogeneic Stem Cell Transplant
- Trial Type
- Observational
- Last Update
- 3 weeks ago
- SparkCures ID
- 1261
- NCT Identifier
- NCT02677064
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.